“…An arbitrary cut‐off point of 30% is currently used for designating ‘mixed’ endometrial stromal and smooth muscle tumors; 1,4 however, the amount of either endometrial stromal or smooth muscle component does not seem to critically determine the clinical behavior of these mixed neoplasms, because recurrence and extensive invasion of the tumor have been observed in tumors composed predominantly of benign appearing smooth muscle components and a minor endometrial stromal tumor components 5 . Among the recurrent tumors, some recurred as a low grade endometrial stromal sarcoma as in our case, 1,6 and some as a mixed form 5,7 . Thus, the histologically distinct stromal and smooth muscle components in the tumor seem to have transdifferentiation along the tumor recurrences or metastases.…”